Association Between Serum Follicle-Stimulating Hormone and Sarcopenia and Physical Disability Among Older Chinese Men: Evidence From a Cross-Sectional Study
Authors:
Open Access
- 4 January 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 8, 724649
Abstract
Background: Sarcopenia is a geriatric syndrome characterized by progressive loss of muscle mass, function and quality and associated with a range of adverse health outcomes including disability. Despite a negative correlation between muscle mass and follicle-stimulating hormone (FSH) levels in postmenopausal women, it is unclear if FSH is associated with sarcopenia and its poor outcomes, especially in older men.Methods: We used cross-sectional data from 360 men aged over 80 who participated in health check-ups to investigate correlations between serum FSH and sarcopenia, individual sarcopenia components, low physical performance (gait speed ≤ 0.8 m/s) and instrumental activities of daily living (IADL) disability. Sarcopenia and severe sarcopenia were diagnosed according to the revised definition of the European Working Group on Sarcopenia in Old People (EWGSOP2).Results: The prevalence of sarcopenia was 17.8% in this population. In binary logistic regression analysis, compared with higher FSH group, lower FSH group showed a significant reduction in the risk of low calf circumference (a surrogate for muscle mass; OR 0.308, 95% CI 0.109–0.868, P = 0.026) after adjusting potential confounders including age, waist circumference, education, exercise, associated biochemical parameters, other sex hormones and high-sensitivity C-reactive protein. The correlation between FSH and low handgrip strength was marginally significant (OR 0.390, 95% CI 0.151–1.005, P = 0.051). No associations were observed between FSH and sarcopenia, severe sarcopenia, and disability in adjusted models.Conclusion: In older men, circulating FSH was not associated with sarcopenia, sarcopenia severity, the majority of its components and adverse health outcome (IADL disability), with the exception of low calf circumference. Further work is needed to better elucidate the association of FSH and low muscle quantity by adopting more accurate measurement method of appendicular skeletal muscle mass such as DXA, CT or MRI.Keywords
This publication has 31 references indexed in Scilit:
- Sarcopenia-Related Parameters and Incident Disability in Older Persons: Results From the “Invecchiare in Chianti” StudyThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2014
- The role of the estrogen receptor in skeletal muscle mass homeostasis and regenerationActa Physiologica, 2014
- Sex hormones and skeletal muscle weaknessBiogerontology, 2013
- Gonadotropins Are Related to Lean Mass in Healthy Postmenopausal WomenEndocrine Research, 2012
- FSH stimulates lipid biosynthesis in chicken adipose tissue by upregulating the expression of its receptor FSHRJournal of Lipid Research, 2012
- Follicle-stimulating hormone is independently associated with lean mass but not BMD in younger postmenopausal womenBone, 2012
- Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actionsCellular and Molecular Life Sciences, 2011
- Changes in Body Composition in Women over Six Years at Midlife: Ovarian and Chronological AgingThe Journal of Clinical Endocrinology & Metabolism, 2007
- Long-Term Testosterone Gel (AndroGel) Treatment Maintains Beneficial Effects on Sexual Function and Mood, Lean and Fat Mass, and Bone Mineral Density in Hypogonadal MenThe Journal of Clinical Endocrinology & Metabolism, 2004
- Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily LivingThe Gerontologist, 1969